Miguel A Teus1,2, Javier Paz Moreno-Arrones1, Beatriz Castaño3, Miguel A Castejon1, Gema Bolivar1. 1. Department of Ophthalmology, Hospital Universitario Príncipe de Asturias, Carretera Alcalá-Meco s/n, Alcalá de Henares, 28805, Madrid, Spain. 2. School of Medicine, University of Alcalá, Alcalá de Henares, Madrid, Spain. 3. Department of Ophthalmology, Hospital Universitario Príncipe de Asturias, Carretera Alcalá-Meco s/n, Alcalá de Henares, 28805, Madrid, Spain. bea_castano90@hotmail.com.
Abstract
PURPOSE: The purpose of this study was to use Triton® SweptSource OCT to evaluate the morphology of blebs formed when eyes are treated with XEN® implants and to compare these with the blebs in successfully functioning eyes after trabeculectomy (TB) and with eyes of healthy controls. METHODS: A cross-sectional, observational study. We analyzed 25 eyes, 15 after TB and 10 with XEN® implants, comparing them with 23 healthy eyes (controls). We evaluated the conjunctival morphology of the eyes using AS-OCT. The main parameters evaluated were bleb height, sub-epithelial fibrosis, epithelial thickness, and changes in intraocular pressure (IOP). RESULTS: We found that the filtering blebs formed in eyes in which a XEN® stent was implanted were significantly flatter (bleb height 417 ± 183 μm) than the blebs formed in TB eyes (bleb height 618 ± 256 μm, p < 0.05). Moreover, sub-epithelial fibrosis did not develop in any of the blebs produced by the XEN stent, whereas some fibrosis was evident in 40% of the blebs that formed after TB (p < 0.05). The epithelium was thicker when the XEN implant was used (65 ± 18.5 μm) than when eyes underwent TB (60 ± 17.7 μm), and it was thicker than in control eyes (51 ± 9.7 μm, p < 0.05). Moreover, the decrease in the IOP induced by the XEN® stent (- 8.5 ± 5.3 mmHg) was similar to that produced by TB (- 8.8 ± 5.2 mmHg, p > 0.05). CONCLUSIONS: Filtering blebs obtained after the introduction of a XEN® stent were morphologically distinct to those produced by TB, and they are more similar to the healthy conjunctiva.
PURPOSE: The purpose of this study was to use Triton® SweptSource OCT to evaluate the morphology of blebs formed when eyes are treated with XEN® implants and to compare these with the blebs in successfully functioning eyes after trabeculectomy (TB) and with eyes of healthy controls. METHODS: A cross-sectional, observational study. We analyzed 25 eyes, 15 after TB and 10 with XEN® implants, comparing them with 23 healthy eyes (controls). We evaluated the conjunctival morphology of the eyes using AS-OCT. The main parameters evaluated were bleb height, sub-epithelial fibrosis, epithelial thickness, and changes in intraocular pressure (IOP). RESULTS: We found that the filtering blebs formed in eyes in which a XEN® stent was implanted were significantly flatter (bleb height 417 ± 183 μm) than the blebs formed in TB eyes (bleb height 618 ± 256 μm, p < 0.05). Moreover, sub-epithelial fibrosis did not develop in any of the blebs produced by the XEN stent, whereas some fibrosis was evident in 40% of the blebs that formed after TB (p < 0.05). The epithelium was thicker when the XEN implant was used (65 ± 18.5 μm) than when eyes underwent TB (60 ± 17.7 μm), and it was thicker than in control eyes (51 ± 9.7 μm, p < 0.05). Moreover, the decrease in the IOP induced by the XEN® stent (- 8.5 ± 5.3 mmHg) was similar to that produced by TB (- 8.8 ± 5.2 mmHg, p > 0.05). CONCLUSIONS: Filtering blebs obtained after the introduction of a XEN® stent were morphologically distinct to those produced by TB, and they are more similar to the healthy conjunctiva.
Authors: A P Wells; J G Crowston; J Marks; J F Kirwan; G Smith; J C K Clarke; R Shah; J Vieira; C Bunce; I Murdoch; P T Khaw Journal: J Glaucoma Date: 2004-12 Impact factor: 2.503
Authors: James F Kirwan; Alastair J Lockwood; Peter Shah; Alex Macleod; David C Broadway; Anthony J King; Andrew I McNaught; Pavi Agrawal Journal: Ophthalmology Date: 2013-09-23 Impact factor: 12.079
Authors: Dao-Yi Yu; William H Morgan; Xinghuai Sun; Er-Ning Su; Stephen J Cringle; Paula K Yu; Philip House; Wenyi Guo; Xiaobo Yu Journal: Prog Retin Eye Res Date: 2009-06-30 Impact factor: 21.198
Authors: Yih-Chung Tham; Xiang Li; Tien Y Wong; Harry A Quigley; Tin Aung; Ching-Yu Cheng Journal: Ophthalmology Date: 2014-06-26 Impact factor: 12.079
Authors: Felix Mathias Wagner; Alexander Karl-Georg Schuster; Julia Emmerich; Panagiotis Chronopoulos; Esther Maria Hoffmann Journal: PLoS One Date: 2020-04-20 Impact factor: 3.240
Authors: Marta Ibarz Barberá; Jose Luis Hernández-Verdejo; Jean Bragard; Javier Burguete; Laura Morales Fernández; Pedro Tañá Rivero; Rosario Gómez de Liaño; Miguel A Teus Journal: Transl Vis Sci Technol Date: 2021-11-01 Impact factor: 3.283